Complementary Meds Used by 17% of Elderly With Cancer

This article originally appeared here.
Share this content:
Complementary Meds Used by 17 Percent of Elderly With Cancer
Complementary Meds Used by 17 Percent of Elderly With Cancer

(HealthDay News) – The prevalence of older people with cancer using complementary medications as they start a chemotherapy regimen is 17%, and is associated with less advanced disease and higher functional status, according to a study published online February 22 in Cancer.

Ronald J. Maggiore, MD, of the University of Chicago Medical Center, and colleagues evaluated the prevalence of complementary medicine use as well as factors associated with its use among 545 patients (mean age, 73 years) about to start chemotherapy for cancer (61% stage IV).

The researchers found that 17% of patients reported using at least one complementary medication, with a mean of two medications used per patient. There was an association between complementary medication use and earlier cancer stage (stage I to II, 29%; stage III to IV, 17%; odds ratio [OR], 2.05) as well as less impairment in instrumental activities of daily living (OR, 1.39).

"Complementary medication use was reported by 17% of older adults with cancer and was more common among those who had less advanced disease (i.e., those receiving adjuvant, potentially curative treatment) and higher functional status," the authors write. "Further studies are needed to determine the association between complementary medication use and cancer outcomes among older adults."

One of the authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs